Riskpilot← Back to searchSign inGet full accessVallneus Samtalsterapi AB
ABDissolvedOrg 5592292469Other human health activities · NACE 8690Est. 20190 employees
Revenue 2023
SEK 958
-93% vs 2022
EBITDA margin
-5481.2%
-25% vs 2022
Equity ratio
26.8%
Financial strength
Net profit 2023
SEK -52K
-25% vs 2022
| Revenue | SEK 958 | -93% |
| EBITDA | SEK -53K | -25% |
| Net profit | SEK -52K | -25% |
| Total assets | SEK 141K | +226% |
| Equity | SEK 38K | -6% |
| Employees | 0 | — |
Legal name
Vallneus Samtalsterapi AB
Org number
5592292469
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
2 december 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Aktiebolaget ska bedriva samtalsterapi. Samtal kommer att föras mellan terapeut och klienter.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 1 | 8 | 13 | 1 |
| Staff expenses | — | — | — | — |
| EBITDA | −44 | −33 | −42 | −53 |
| Depreciation & amort. | −0 | −0 | — | — |
| EBIT | −44 | −33 | −42 | −53 |
| Net financials | — | — | 0 | 0 |
| Profit before tax | −44 | −33 | −42 | −52 |
| Tax | −0 | −0 | — | — |
| Net profit | −44 | −33 | −42 | −52 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 60 | 85 | 43 | 141 |
| Equity | 56 | 82 | 40 | 38 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 5 | 3 | 3 | 103 |
| Total debt | 5 | 3 | 3 | 103 |
EBITDA margin
-5481.2%
This company
15.8%
Market median
-34791% vs market
20202023
Equity ratio
26.8%
This company
38.2%
Market median
-30% vs market
20202023
Return on equity
-138.8%
This company
18.4%
Market median
-854% vs market
20202023
Net profit margin
-5476.6%
This company
8.1%
Market median
-67712% vs market
20202023
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202023
Debt / equity
2.73×
This company
0.62×
Market median
-340% vs market
20202023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-12-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vallneus Samtalsterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Birgitta Killgren Jonsson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Åsa Margareta Vallneus | Board of Directors | 0 companies |
| Sten Daniel Vallneus | Deputy Board Member | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Kjell Erik Sjunnesson | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |